Balance Ophthalmics, Inc.

Balance Ophthalmics is an ophthalmic medical technology company focused on innovative solutions for glaucoma management, the leading cause of irreversible blindness globally. The company develops non-pharmaceutical, non-surgical therapies designed to lower intraocular pressure in glaucoma patients. Their flagship product, FSYX™, is a novel device-based therapy administered during sleep that addresses nocturnal intraocular pressure spikes—a critical mechanism in glaucoma progression. Balance Ophthalmics positions itself as a leader in ophthalmic medical technology, serving eye care professionals and their patients with solutions that fill unmet needs in glaucoma treatment. The company emphasizes innovation in pressure management and brings a differentiated approach to a disease affecting millions worldwide with significant vision-threatening potential.